Skip to main content

rilpivirine

Generic: RILPIVIRINE HYDROCHLORIDE·Brand: EDURANT, EDURANT PED, RILPIVIRINE HYDROCHLORIDE

rilpivirine: 1 clinical trial tracked.

rilpivirine evidence translation

What we can confirm

1 tracked trial

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about rilpivirine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence1 indications · 1 study sponsors

Related indications

HIV Infections
Clinical Trial Registry Records (1)

A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of Switching to Long-acting Antiretroviral Therapy of Broadly Neutralizing Antibodies Teropavimab and Zinlirvimab in Combination With the Capsid Inhibitor Lenacapavir Twice-Yearly Versus Cabotegravir and Rilpivirine Every 8 Weeks in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

NCT07682961Registry updated 2026-08-14·Phase 3·GILD
Recruiting

Primary endpoint: Proportion of Participants With HIV-1 ribonucleic acid (RNA) ≥ 50 Copies/mL at Week 52 as Defined by the United States (US) Food and Drug Administration (FDA) Snapshot Algorithm.

InterventionalRandomizedopen590 targetStarted 2026-07Completion 2033-0319 sites · Australia, Japan, United StatesGilead Sciences